Infection with hepatitis B and C viruses and risk of lymphoid malignancies in theEuropean Prospective Investigation into Cancer and Nutrition (EPIC)
| العنوان: | Infection with hepatitis B and C viruses and risk of lymphoid malignancies in theEuropean Prospective Investigation into Cancer and Nutrition (EPIC) |
|---|---|
| المؤلفون: | Anja Olsen, Signe Borgquist, Rosario Tumino, Carlotta Sacerdote, Pagona Lagiou, Elio Riboli, Kim Overvad, Sara Regnér, Christina Bamia, Laudina Rodríguez, Kay-Tee Khaw, Bas Bueno-de-Mesquita, Paolo Vineis, Carmen Navarro, Nikolaus Becker, Manuela M. Bergmann, Anne Tjønneland, María José Sánchez, Nicholas J. Wareham, Rudolf Kaaks, Salvatore Panico, Pascale Berthillon, Roel Vermeulen, Ruth C. Travis, Mauro Lise, Beatrice Melin, Domenico Palli, Shu Chun Chuang, Göran Hallmans, Sabina Rinaldi, Alexandra Nieters, Leila Luján Barroso, Antonia Trichopoulou, Silvia Franceschi, Christian Trepo, Pierre Hainaut, Miren Dorronsoro, Heiner Boeing, Sabina Sieri, Aurelio Barricarte, Petra H.M. Peeters |
| المساهمون: | Franceschi, S, Lise, M, Trépo, C, Berthillon, P, Chuang, Sc, Nieters, A, Travis, Rc, Vermeulen, R, Overvad, K, Tjønneland, A, Olsen, A, Bergmann, Mm, Boeing, H, Kaaks, R, Becker, N, Trichopoulou, A, Lagiou, P, Bamia, C, Palli, D, Sieri, S, Panico, Salvatore, Tumino, R, Sacerdote, C, Bueno de Mesquita, B, Peeters, Ph, Rodríguez, L, Barroso, Ll, Dorronsoro, M, Sánchez, Mj, Navarro, C, Barricarte, A, Regnér, S, Borgquist, S, Melin, B, Hallmans, G, Khaw, Kt, Wareham, N, Rinaldi, S, Hainaut, P, Riboli, E, Vineis, P., Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), E16, IFR Laennec (IL), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre de Recherche en Cancérologie de Lyon (CRCL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (CRCL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Molecular Epidemiology, Center of Chronic Immunodeficiency, University Medical Center and University of Freiburg, Institute for Medical Biostatistics and Medical Informatics, University Medical Center and University of Freiburg, Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Section of Epidemiology, Aarhus University [Aarhus], Danish Cancer Society Research Center, Cancer Epidemiology Institute, Danish Cancer Society, Epidemiology, Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Hellenic Health Foundation, WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene-Epidemiology and Medical Statistics-Athens Medical School, WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Department of Clinical and Experimental Medicine, Università degli studi di Napoli Federico II, Cancer Registry, Azienda Ospedaliera 'Civile M.P.Arezzo', CPO Piemonte, National Institute for Public Health and the Environment [Bilthoven] (RIVM), Department of Gastroenterology and Hepatology, University Medical Centre, Julius Centre for Health Sciences and Primary Care, VU University Medical Center [Amsterdam], Julius Center for Health Sciences and Primary Care, Public Health and Participation Directorate, Health and Health Care Services Council, Epidemiology and Health Information, Public Health Department of Gipuzkoa, Consorcio de Investigación Biomédica en Red especializado en Epidemiología y Salud Pública (CIBERESP), Los Centros de Investigación Biomédica en Red (CIBER), Granada Cancer Registry, Andalusian School of Public Health [Granada], CIBERESP, CIBER Epidemiologia y Salud Pública, Epidemiology Department, Murcia Health Council, Navarre Public Health Institute, Department of Oncology, Lund University [Lund]-Lund University Hospital, Department of Radiation Sciences and Oncology, Umeå University, Department of Public Health and Clinical Medicine, Department of Public Health and Primary Care, University of Cambridge [UK] (CAM), Medical Research Council, Addenbrooke's Hospital-Epidemiology Unit, International Agency for Cancer Research (IACR), Sect Mech Carcinogenesis, School of Public Health, Imperial College London, Centre for Environment and Health, Imperial College London-School of public health, The University of Hong Kong (HKU)-The University of Hong Kong (HKU), Human Genetics Foundation (HuGeF), Università degli studi di Torino (UNITO), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Freiburg University Medical Center, Civile - M.P.Arezzo Hospital, Lund University Hospital-Lund University [Lund] |
| المصدر: | Franceschi, S, Lise, M, Trépo, C, Berthillon, P, Chuang, S-C, Nieters, A, Travis, R C, Vermeulen, R, Overvad, K, Tjønneland, A, Olsen, A, Bergmann, M M, Boeing, H, Kaaks, R, Becker, N, Trichopoulou, A, Lagiou, P, Bamia, C, Palli, D, Sieri, S, Panico, S, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, B, Peeters, P H M, Rodríguez, L, Barroso, L L, Dorronsoro, M, Sánchez, M-J, Navarro, C, Barricarte, A, Regnér, S, Borgquist, S, Melin, B, Hallmans, G, Khaw, K-T, Wareham, N, Rinaldi, S, Hainaut, P, Riboli, E & Vineis, P 2011, ' Infection with Hepatitis B and C Viruses and Risk of Lymphoid Malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC) ', Cancer Epidemiology, Biomarkers & Prevention, vol. 20, no. 1, pp. 208-14 . https://doi.org/10.1158/1055-9965.EPI-10-0889 Cancer Epidemiology, Biomarkers and Prevention Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research, 2011, 20 (1), pp.208-14. ⟨10.1158/1055-9965.EPI-10-0889⟩ |
| سنة النشر: | 2011 |
| مصطلحات موضوعية: | Male, HBsAg, Epidemiology, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, MESH: Lymphoma, Non-Hodgkin, MESH: Risk Factors, Risk Factors, immune system diseases, hemic and lymphatic diseases, Prospective Studies, MESH: Middle Aged, Lymphoma, Non-Hodgkin, virus diseases, Hepatitis C, Hepatitis B, Middle Aged, MESH: Case-Control Studies, 3. Good health, European Prospective Investigation into Cancer and Nutrition, Europe, Oncology, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Female, medicine.medical_specialty, Hepatitis C virus, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, Internal medicine, medicine, Humans, Risk factor, Hepatitis B virus, MESH: Hepatitis C, MESH: Humans, MESH: Hepatitis B, business.industry, Odds ratio, medicine.disease, digestive system diseases, MESH: Male, MESH: Prospective Studies, Case-Control Studies, Immunology, MESH: Europe, business, MESH: Female |
| الوصف: | Background: Case–control studies suggested a moderate, but consistent, association of hepatitis C virus (HCV) infection with lymphoid tissue malignancies, especially non–Hodgkin lymphoma (NHL). More limited data suggested that hepatitis B virus (HBV) infection might also be associated with NHL. However, prospective studies on the topic are few. Methods: A nested case–control study was conducted in eight countries participating in the EPIC prospective study. Seven hundred thirty-nine incident cases of NHL, 238 multiple myeloma (MM), and 46 Hodgkin lymphoma (HL) were matched with 2,028 controls. Seropositivity to anti-HCV, anti-HBc, and HBsAg was evaluated and conditional logistic regression was used to estimate odds ratios (OR) and corresponding 95% confidence intervals (CI) for NHL, MM, or HL, and their combination. Results: Anti-HCV seropositivity among controls in different countries ranged from 0% to 5.3%; HBsAg from 0% to 2.7%; and anti-HBc from 1.9% to 45.9%. Similar nonsignificant associations were found with seropositivity to HBsAg for NHL (OR = 1.78; 95% CI: 0.78–4.04), MM (OR = 4.00; 95% CI: 1.00–16.0), and HL (OR = 2.00; 95% CI: 0.13–32.0). The association between HBsAg and the combination of NHL, MM, and HL (OR = 2.21; 95% CI: 1.12–4.33) was similar for cancer diagnosed less than 3 and 3 or more years after blood collection. No significant association was found between anti-HCV and NHL, MM, or HL risk, but the corresponding CIs were very broad. Conclusions: Chronic HBV infection may increase the risk of lymphoid malignancies among healthy European volunteers. Impact: Treatment directed at control of HBV infection should be evaluated in HBsAg-seropositive patients with lymphoid tissue malignancies. Cancer Epidemiol Biomarkers Prev; 20(1); 208–14. ©2011 AACR. |
| وصف الملف: | STAMPA |
| تدمد: | 1055-9965 1538-7755 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5002959482bb9374fa648f48055e23f4 http://hdl.handle.net/11588/428757 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....5002959482bb9374fa648f48055e23f4 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 10559965 15387755 |
|---|